Skip to main content
The BMJ logoLink to The BMJ
letter
. 1990 Mar 17;300(6726):745–746.

Interleukin 2.

PMCID: PMC1662454  PMID: 2322727

Full text

PDF

Page 745

745

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hamblin T. J. Interleukin 2. BMJ. 1990 Feb 3;300(6720):275–276. doi: 10.1136/bmj.300.6720.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Retsas S., Gershuny A. R. Central nervous system involvement in malignant melanoma. Cancer. 1988 May 1;61(9):1926–1934. doi: 10.1002/1097-0142(19880501)61:9<1926::aid-cncr2820610934>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  3. Rosenberg S. A., Packard B. S., Aebersold P. M., Solomon D., Topalian S. L., Toy S. T., Simon P., Lotze M. T., Yang J. C., Seipp C. A. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med. 1988 Dec 22;319(25):1676–1680. doi: 10.1056/NEJM198812223192527. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES